Quarterly report pursuant to Section 13 or 15(d)

Equity Compensation - Schedule of Stock Option Activity (Details)

v3.24.2.u1
Equity Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 30, 2024
Jun. 29, 2024
Dec. 30, 2023
Stock Options      
Unvested, beginning balance outstanding (in shares) 544,350 544,350  
Granted (in shares)   0  
Exercised (in shares)   (2,069)  
Vested (in shares)   (113,252)  
Forfeited (in shares)   (29,835)  
Unvested, ending balance outstanding (in shares)   399,194 544,350
Vested not exercised (in shares)   286,358 175,175
Weighted-Average Grant Date Fair Value      
Beginning balance outstanding (in dollars per share) $ 4.5 $ 4.5  
Granted (in dollars per share)   0  
Exercised (in dollars per share)   0  
Vested (in dollars per share)   4.5  
Forfeited (in dollars per share)   5.1  
Ending balance outstanding (in dollars per share)   4.4 $ 4.5
Vested not exercised (in dollars per share)   4.5 4.5
Weighted-Average Exercise Price, per share      
Beginning balance outstanding (in dollars per share) $ 9.4 9.4  
Granted (in dollars per share)   0  
Exercised (in dollars per share)   9.5  
Vested (in dollars per share)   0  
Forfeited (in dollars per share)   10.2  
Ending balance outstanding (in dollars per share)   9.3 9.4
Vested not exercised (in dollars per share)   $ 9.4 $ 9.4
Weighted Average Remaining Contractual Life (in years) 8 years 4 months 24 days 7 years 10 months 24 days  
Weighted Average Remaining Contractual Life, Vested (in years)   7 years 9 months 18 days  
Weighted Average Remaining Contractual Life, Forfeited (in years)   8 years 4 months 24 days  
Weighted Average Remaining Contractual Life, Vested not exercised (in years)   7 years 10 months 24 days 8 years 3 months 18 days
Aggregate Intrinsic Value   $ 1.4 $ 2.0
Aggregate Intrinsic Value, Vested   0.4  
Aggregate Intrinsic Value, Forfeited   0.1  
Aggregate Intrinsic Value, Vested not exercised   $ 0.9 $ 0.6